Literature DB >> 9225824

Elevated serum lipoprotein(a) levels in young women with endometriosis.

D Crook1, R Howell, M Sidhu, D K Edmonds, J C Stevenson.   

Abstract

Elevated serum lipoprotein(a) [Lp(a)] levels increase the risk of cardiovascular disease if levels of low-density lipoproteins (LDLs) are also high. The biological function of Lp(a) is unknown, but plasma levels may be elevated in inflammatory disease. Endometriosis is a common gynecologic disorder in which endometrial tissue is found outside of the lining of the uterine cavity. There is an immune component to this condition whereby the number of peritoneal macrophages is increased and the level of prostanoids and cytokines in peritoneal fluid is elevated. In the present study, we measured serum lipid, lipoprotein, and apolipoprotein levels in 29 women with endometriosis and in 29 matched healthy controls. Fasting serum triglyceride and apolipoprotein (apo) Al levels were higher in women with endometriosis (+28.1%, P < .001, and +12.3%, P < .01, respectively), but there were no significant differences in LDL or high-density lipoprotein (HDL) cholesterol levels. Serum Lp(a) levels were fivefold higher (P < .01) in the patients (median, 15.0 mg/dL; range, 0.05 to 60.0) than in controls (median, 3.1 mg/dL; range, 0.05 to 57.2). The distribution of apo(a) isoforms was similar in the two groups, but in women with endometriosis the individual apo(a) isoforms tended to be associated with higher serum Lp(a) levels. Endometriosis may represent a relatively common condition in which to investigate the role of Lp(a) in human metabolism.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9225824     DOI: 10.1016/s0026-0495(97)90115-3

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  8 in total

1.  Apolipoprotein E polymorphisms and spontaneous pregnancy loss in patients with endometriosis.

Authors:  Madeline S Collazo; Tirtsa Porrata-Doria; Idhaliz Flores; Summer F Acevedo
Journal:  Mol Hum Reprod       Date:  2012-01-20       Impact factor: 4.025

2.  Endometriosis and cardiovascular disease.

Authors:  Benjamin Marchandot; Anais Curtiaud; Kensuke Matsushita; Antonin Trimaille; Aline Host; Emilie Faller; Olivier Garbin; Chérif Akladios; Laurence Jesel; Olivier Morel
Journal:  Eur Heart J Open       Date:  2022-02-02

3.  Reply to Kielb et al. Untapped Potential for Female Patients? Comment on "Lucà et al. Update on Management of Cardiovascular Diseases in Women. J. Clin. Med. 2022, 11, 1176".

Authors:  Fabiana Lucà; Furio Colivicchi; Roberta Rossini; Carmine Riccio; Sandro Gelsomino; Michele Massimo Gulizia
Journal:  J Clin Med       Date:  2022-05-30       Impact factor: 4.964

4.  Proteomic analysis of endometrium from fertile and infertile patients suggests a role for apolipoprotein A-I in embryo implantation failure and endometriosis.

Authors:  Jan J Brosens; Andrea Hodgetts; Fahkera Feroze-Zaidi; J Robert A Sherwin; Luca Fusi; Madhuri S Salker; Jenny Higham; Gillian L Rose; Takeshi Kajihara; Steven L Young; Bruce A Lessey; Patrick Henriet; Paul R Langford; Asgerally T Fazleabas
Journal:  Mol Hum Reprod       Date:  2009-12-14       Impact factor: 4.025

5.  Long-term Health Consequences of Endometriosis - Pathways and Mediation by Treatment.

Authors:  Leslie V Farland; Holly R Harris
Journal:  Curr Obstet Gynecol Rep       Date:  2020-05-29

6.  [Research progress on biomarkers for endometriosis based on lipidomics].

Authors:  Cuicui Lin; Zhengyun Chen; Chunyan Wang; Yongmei Xi
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2020-12-25

7.  Cardiovascular risk factors among women with self-reported infertility.

Authors:  Shruthi Mahalingaiah; Fangui Sun; J Jojo Cheng; Erika T Chow; Kathryn L Lunetta; Joanne M Murabito
Journal:  Fertil Res Pract       Date:  2017-04-11

8.  Lipidomic Alterations and PPARα Activation Induced by Resveratrol Lead to Reduction in Lesion Size in Endometriosis Models.

Authors:  Zhengyun Chen; Chunyan Wang; Cuicui Lin; Lifeng Zhang; Huimei Zheng; Yong Zhou; Xiaoyong Li; Chen Li; Xinmei Zhang; Xiaohang Yang; Minxin Guan; Yongmei Xi
Journal:  Oxid Med Cell Longev       Date:  2021-09-11       Impact factor: 6.543

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.